Attached files
file | filename |
---|---|
10-K - Sonoma Pharmaceuticals, Inc. | v187499_10k.htm |
EX-23.1 - Sonoma Pharmaceuticals, Inc. | v187499_ex23-1.htm |
EX-31.1 - Sonoma Pharmaceuticals, Inc. | v187499_ex31-1.htm |
EX-31.2 - Sonoma Pharmaceuticals, Inc. | v187499_ex31-2.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
(18
U.S.C. SECTION 1350)
Pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
section 1350, chapter 63 of title 18, United States Code), each of the
undersigned officers of Oculus Innovative Sciences, Inc., a California
corporation (the “Company”), does hereby certify, to such officer’s knowledge,
that:
The
annual report on Form 10-K for the year ended March 31, 2010 (the “Form 10-K”)
of the Company fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934, and the information contained in the Form
10-K fairly presents, in all material respects, the financial condition and
results of operations of the Company.
Date:
June 8, 2010
/s/ Hojabr Alimi
|
|
Hojabr
Alimi
|
|
Chief
Executive Officer and Principal Executive Officer
|
|
/s/ Robert E. Miller
|
|
Robert
E. Miller
|
|
Chief
Financial Officer, Principal Financial Officer and
|
|
Principal
Accounting Officer
|